Source: 411Cancer.com “Cancer Experts leading the way to optimal cancer care.”
According to results presented at the 2003 European Hematology Association meeting, further evidence indicates that Aranesp∆ (darbepoetin alfa) is effective at improving anemia and fatigue in patients with lymphoid cancers.
Lymphoid cancers, sometimes referred to as lymphoproliferative diseases, are cancers that originate in the immune system. Examples of lymphoid cancers include Hodgkin’s disease, non-Hodgkin’s disease, chronic lymphocytic leukemia and multiple myeloma. A mainstay of treatment for lymphoid cancers involves chemotherapy, which can cause anemia.